All lobbying filings

MEHLMAN CONSULTING, INC.

Lobbying for AMERICA'S HEALTH INSURANCE PLANS

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 3

S 1105
No UPCODE Act
HR 247
Health Care Affordability Act of 2025
S 46
Health Care Affordability Act of 2025

Lobbying activity 4

Health Issues

Issues related to the accessibility and affordability of healthcare, surprise medical billing.

Medicare/Medicaid

Issues related to Medicare payments and Medicare Advantage Prescription Drug Pricing. Medicaid S.1105 - No UPCODE Act CY 2027 Medicare Advantage Rate Notice.

Taxation/Internal Revenue Code

Enhanced premium tax credits Issues related to HSAs. H.R.247/S.46 - Health Care Affordability Act of 2025

Pharmacy

Prescription drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.